Vascular endothelial growth factor and thymidine phosphorylase expression in salivary gland tumors with distinct metastatic behavior

J Oral Pathol Med. 2011 Jul;40(6):456-9. doi: 10.1111/j.1600-0714.2010.00980.x. Epub 2010 Dec 8.

Abstract

Background: Metastasis of salivary gland tumors has a negative impact on survival. Angiogenesis and its factors are potential markers for predicting metastasis in different malignant tumors, but this is not the case for salivary gland tumors.

Methods: Salivary gland tumors of distinct biologic behavior were analyzed according to the semiquantitative immunoexpression of vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP).

Results: Vascular endothelial growth factor expression was predominantly weak in benign tumors. Weak TP expression was observed in 100% cases of benign tumors and in 74.3% of primary malignant tumors. High VEGF and TP expression levels were significantly associated with primary malignant tumors but not with primary non-metastasizing and primary metastasizing malignant tumors or with subtypes of malignant tumors.

Conclusions: Vascular endothelial growth factor and TP expression levels discriminate benign and malignant tumors but cannot predict metastasis from non-metastasizing tumors.

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma / metabolism
  • Carcinoma / pathology
  • Chi-Square Distribution
  • Child
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Salivary Gland Neoplasms / metabolism*
  • Salivary Gland Neoplasms / pathology
  • Thymidine Phosphorylase / biosynthesis*
  • Vascular Endothelial Growth Factor A / biosynthesis*
  • Young Adult

Substances

  • Vascular Endothelial Growth Factor A
  • Thymidine Phosphorylase